EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Postal POS

Postal Reform proposals and their impact on 6 day mail delivery

Contacted: HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); White House Office; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); SENATE; Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Executive Office of the President (EOP)

Health Issues HCR

Regulatory policies related to health reform legislation: structure, drug benefits, disclosure Regulatory implementation of HITECH/Accounting of Disclosures Issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs).

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; Internal Revenue Service (IRS); Government Accountability Office (GAO); Office of Personnel Management (OPM); Federal Trade Commission (FTC); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General reg/leg Part D issues such as direct negotiation (budget proposals). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors' prompt pay discounts from the definition of Average Sales Price. Medicare audit and preferred network restrictions. S. 867, Medicare Prescription Drug Integrity andAnd Transparency Act of 2013. General issues and legislation (HR 3392) regarding combatting Rx abuse in Medicare and Medicaid (pharmacy lock-in, etc)

Contacted: Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); White House Office; Executive Office of the President (EOP)

Bills named: S. 867 (113th), H.R. 3392 (113th)

Pharmacy PHA

Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.

Contacted: Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); White House Office; Office of Personnel Management (OPM)

Bills named: S. 867 (113th), H.R. 1367 (113th), H.R. 3392 (113th)

Defense DEF

Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill

Contacted: Labor, Dept of (DOL); Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; White House Office; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); SENATE; Office of Personnel Management (OPM); Federal Trade Commission (FTC); Government Accountability Office (GAO)

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform legislation

Contacted: SENATE; White House Office; Food & Drug Administration (FDA); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Executive Office of the President (EOP); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Internal Revenue Service (IRS)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for purposes of negotiating with payers (HR 1188)

Contacted: Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Congressional Budget Office (CBO); Government Accountability Office (GAO); White House Office; HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Internal Revenue Service (IRS)

Bills named: H.R. 1188 (113th)